European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-30

ASSURED Point-of-Care Device for Syphilis and HIV in Pregnant Women and New Born

Cel

The incidence of mother to child transmission of syphilis and HIV is still increasing and these infections are major cause of early death and severe morbidity of the young infant. Most case of congenital syphilis and HIV infection occur in hard to reach populations. The availability of an affordable and patient and user friendly point-of-care test that allows same day testing and treatment would save many newborn lives. We intend to develop, validate and start manufacturing of a complete new and innovative concept of a versatile multi-analyte device for the diagnosis of congenital syphilis and HIV co-infections. Equipped with a simple portable reader for transmission and central information storage epidemiological information may be collected and analysed to guide active surveillance and prevention programs. The market for point-of-care test is rapidly growing and the development of this device will allow the participating SMEs to increase their research capacity and to strengthen and expand their market position. Potential this multi-analyte assay will also find other applications such as in the diagnosis of infectious diseases that are in the same differential diagnosis, testing of drugs of abuse and combinations of tumor markers.

Zaproszenie do składania wniosków

FP7-HEALTH-2012-INNOVATION-2
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

HET KONINKLIJK INSTITUUT VOOR DE TROPEN
Wkład UE
€ 885 532,38
Adres
MAURITSKADE 63
1092 AD Amsterdam
Niderlandy

Zobacz na mapie

Region
West-Nederland Noord-Holland Groot-Amsterdam
Rodzaj działalności
Research Organisations
Kontakt administracyjny
Larissa Buschmann (Ms.)
Linki
Koszt całkowity
Brak danych

Uczestnicy (5)